Zentalis Pharmaceuticals, Inc. (ZNTL) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $221.0K | -62.1% |
| 2023 | $583.0K | -77.1% |
| 2022 | $2.55M | -58.3% |
| 2021 | $6.11M | +705.7% |
| 2020 | $758.0K | +115.3% |
| 2019 | $352.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $221.0K | -62.1% |
| 2023 | $583.0K | -77.1% |
| 2022 | $2.55M | -58.3% |
| 2021 | $6.11M | +705.7% |
| 2020 | $758.0K | +115.3% |
| 2019 | $352.0K | — |